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Abstract
Background: The association between human papillomavirus (HPV) types and oral lesions has been shown in many studies.
Considering the significance that HPV has in the development of malignant and potentially malignant disorders of the oral
mucosa, the purpose of this study was to investigate the prevalence of HPV DNA in different oral lesions. In addition, we
wanted to elucidate whether the HPV infection is associated predominantly with either the lesion or a particular anatomic
site of the oral cavity.
Methodology/Principal Findings: The study included 246 subjects with different oral lesions, and 73 subjects with
apparently healthy oral mucosa (controls). The oral lesions were classified according to their surface morphology and clinical
diagnosis. The epithelial cells were collected with a cytobrush from different topographic sites in the oral cavity of the oral
lesions and controls. The presence of HPV DNA was evaluated by consensus and type-specific primer-directed polymerase
chain reaction. The HPV positivity was detected in 17.7% of oral lesions, significantly more than in apparently healthy
mucosa (6.8%), with a higher presence in benign proliferative mucosal lesions (18.6%). High-risk HPV types were
predominantly found in potentially malignant oral disorders (HPV16 in 4.3% and HPV31 in 3.4%), while benign proliferative
lesions as well as healthy oral mucosa contained mainly undetermined HPV type (13.6 and 6.8%, respectively).
Conclusions/Significance: The distribution of positive HPV findings on the oral mucosa seems to be more associated with a
particular anatomical site than the diagnosis itself. Samples taken from the vermilion border, labial commissures, and hard
palate were most often HPV positive. Thus, topography plays a role in HPV prevalence findings in oral lesions. Because of
the higher prevalence of the high-risk HPV types in potentially malignant oral disorders, these lesions need to be
continuously controlled and treated.
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Introduction
Oral lesions have different etiology, although most of them can
be largely attributed to environmental exposures. Tobacco use,
chewing areca nuts, and alcohol consumption are well-established
risk factors of various tumors of the oral cavity [1]. Infectious
agents also play an important role in the etiology of oral lesions
[2]. For instance, human papillomaviruses (HPV) seem to be
associated with a subset of oral benign proliferative and malignant
lesions, the head and neck carcinoma, notably carcinoma of the
oropharynx, tonsils and tongue [3]. Thus, HPV-positive oropha-
ryngeal tumors are associated with oral sex, under 60 years of age,
infrequent p53 gene mutation, and a more favorable clinical
outcome, while HPV-negative carcinoma is associated with
smoking, excessive alcohol use, above 60 years of age, frequent
p53 gene mutation, and poor prognosis [4].
Mucosal (alpha genus) HPV types are known to infect both the
genital and the upper respiratory tract [5]. Certain HPV types,
notably types 16 and 18 causing primarily carcinoma of the cervix
are recognized as human carcinogens, and are called high-risk
(HR) types [6] In contrast, low-risk (LR) types, the most common
being HPV types 6 and 11, primarily cause genital warts and
laryngeal papillomas, and are rarely found in tumors [6]. High-risk
HPV types can also cause other anogenital as well as upper
aerodigestive tract carcinomas in women and men. Thus, HPV
contributes to 47% oropharyngeal carcinomas and 11% other
carcinomas of the oral cavity (tonsils and tongue), and HPV 16 is,
as expected, the most commonly found type in oropharyngeal
(90%) and oral carcinoma (96%) [7].
Earlier studies investigating the prevalence of HPV in oral
carcinoma, potentially malignant disorders as well as in apparently
healthy mucosa were inconsistent. Thus, the prevalence of HPV in
normal oral mucosa, oral potentially malignant disorders and oral
malignancies varies from 0 to 70%, 0 to 85%, and 0 to 100%,
respectively (reviewed by Ha & Califano, 2004) [8]. The authors
attributed those discrepancies to sampling variation and limita-
tions of the molecular techniques used in different studies. Indeed,
Kellokoski et al. (1992) showed that the same samples taken from
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healthy oral mucosa were positive for HPV in 3.8% by dot blot
hybridization, while in 29.4% cases with polymerase chain
reaction (PCR) [9]. In the recent meta-analysis, Syrja¨nen et al.
(2011) pointed out that the sampling (oral scrapings, biopsies) is
critical in the evaluation of HPV prevalence in oral specimens as
well, and when the same sampling technique was used for both
cases and controls, a strong association between HPV and oral
potentially malignant disorders was found [10].
In this study we wanted to elucidate whether HPV infection is
linked predominantly with either a particular disease or the site of
infection in the mouth since this data is lacking. In addition, as
there is no published data regarding HPV infection distribution in
oral mucosa in Croatian population, the second aim of this study
was to evaluate the prevalence of HPV infection and particular
HPV types in different oral lesions in this population.
Materials and Methods
Study population
Patients with clinically distinct lesions of the oral mucosa
referred to the Department of Oral medicine, School of Dental
Medicine, University of Zagreb from 1995 to 2011, were included
in this study. In total, there were 246 subjects with diagnosis, and
73 subjects with apparently healthy oral mucosa (controls). Lesions
were initially diagnosed according to clinical features and
confirmed by histopathologic analysis [11].
Ethics Statement
Before the year 2001 verbal patient consent was obtained at the
time of sample collection, and since then, written informed consent
has been obtained from the participants. Both the relevant patient
data (age, histopathological diagnosis, HPV testing results) and the
DNA extracted from oral specimens were processed anonymously.
HPV testing was done on demand through Laboratory service
request forms, which had to be signed and stamped by the
practicing dentist, and approved by The Rudjer Boskovic Institute
of Zagreb. The whole study was approved by the Ethical Board of
the School of Dental Medicine, University of Zagreb that is in line
with the Helsinki declaration (DoH/Oct2008).
Sample collection and processing
Scrapings of oral mucosa epithelial cells were taken with a
cytobrush (Medscand AB, Sweden) from the site(s) of clinically
visible lesion (coded according to the WHO oral topography chart)
[12]. In control subjects (n = 73) only one sample was taken, which
included several topographic locations (bilateral buccal, vestibular,
retrocomissural, lingual, and sublingual mucosa), and was coded in
this study as ‘‘whole oral mucosa’’. In addition, 23 samples from
widespread oral lesions (stomatitis, lichen ruber planus, and lichen ruber
erosivus) were taken from several topographic locations and also
nominated ‘‘whole oral mucosa’’ samples. The oral lesions were
classified either by morphology, according to Nikitakis N.G. (2005)
[13] or clinical diagnosis. Specifically, the premalignant oral
lesions classified according to Warnakulasuriya S. et al. (2007)
[14], were confirmed by histopathology [11].
Samples were collected in TES buffer (10 mM Tris-HCl;
pH 7.5, 1 mM EDTA, pH 7.9; 0.5% SDS), frozen at 220uC, and
transported to the laboratory for HPV detection and genotyping.
DNA was isolated by the high salt method which allows the
precipitation of proteins. Briefly, oral cell suspensions were treated
with proteinase K (50 mg/ml) in TES buffer overnight at 37uC or
2 h at 56uC. Then, 1/3 volume of 5 M NaCl was added to the
suspension, after 15–30 min incubation at 4uC, and 15 min
centrifugation at 4uC, and 14,000 g, the supernatant was carefully
collected, and treated with 2 volumes of 96% cold (220uC)
ethanol. The precipitation of DNA was facilitated by incubation at
least 2 hour at220uC, and 15 min at270uC. The DNA was then
collected after 15 min centrifugation at 4uC, and 14,000 g, one
washing of excess salt, and a second short centrifugation, and
resuspended in ultra pure sterile water (50–100 ml). The quality
and quantity of DNA was determined spectrophotometrically.
Human papillomavirus detection and typing
Detection and genotyping of alpha genus HPV types was done
as described previously [15]. Briefly, in house polymerase chain
reactions (PCR) were performed using MY09/11 or PGMY09/11
consensus PCR primers followed by type-specific PCR amplifying
HPV types 6/11, 16, 18, 31, 33, 45, 52, and 58 in 4 separate
multiplex reactions for all samples irrespective of the initial
consensus PCR results. Negative or very weakly positive samples
by MY/PGMY09/11 and type-specific PCR were further
analyzed by L1C1/L1C2-1/L1C2-2, and/or GP5+/6+ consensus
PCR. Human beta-globin was amplified together with the MY09/
11 or PGMY09/11 consensus primers to verify the suitability of
the isolated DNA for PCR. The PCR was performed with 5 ng/ml
of DNA in each reaction and each run included positive and
negative controls (all reaction components except DNA). All
standard procedures to avoid DNA contamination were applied.
Statistical data analysis
Patient data was recorded in the MS Access database and
analyzed in MS Excel (Microsoft, USA). Chi square test and Chi
square test for trend were used to determine statistically significant
differences between sample groups and were calculated using
Graph Pad Prism (GraphPad software, USA). P values,0.05 were
considered statistically significant.
Results
A total of 327 samples from 319 patients collected during the
period from 1995 and 2011 were successfully analyzed for the
presence of HPV DNA. In total, there were 204 lesions above oral
mucosa surface (i.e. keratosis, hyperplasia), and 50 lesions of oral
epithelium that affect only the tissue beneath the oral mucosa
surface (i.e. erosions, ulcerations). In addition, there were 73
samples collected from patients without any clinically visible
lesions or symptoms, and they served as a control group in this
study. The patients were characterized by a total of 343 referring
diagnosis descriptions. The majority of patients had only 1 given
diagnosis (n = 300), 16 patients had 2 different diagnosis, while 3
patients each had 3, 4, or 5 different diagnosis throughout the
study period, respectively. These clinical diagnoses were grouped
into the 3 following categories: 1) potentially malignant disorders
(leukoplakia [n = 63], lichen ruben planus [n= 39], lichen ruber erosivus
[n = 8], and eritroleukoplakia [n = 6]); 2) benign proliferative lesions
(papilloma [n = 38], verruca vulgaris [n = 21], hyperkeratosis [n = 12],
hyperplasia [n = 15], condyloma accuminata [n = 1], and leukoplakia
villosa [n = 1]); and 3) inflammatory lesions (stomatitis [n = 18],
ulceration [n= 17], glossitis [n = 13], chelitis [n = 7], reactio lichenoides
[n = 6], and gingivitis [n= 5]).
Table 1 presents the distribution of oral lesion by morphology
and diagnosis according to gender and HPV positivity irrespective
of topography. There were 203 women (average age 45.8616.5
years, median 44) and 116 men (average age 41.5618.0 years,
median 38). Men had significantly more positive HPV lesions (27.1
vs 13.0%; p= 0.0096). The majority of HPV positive lesions in
men were lesions above oral mucosa, while in women majority
were beneath oral mucosa (31.4 vs 17.1%, respectively), but there
HPV in Oral Mucosa
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were no statistical difference (p.0.05). In addition, men had more
HPV positive potentially malignant disorders, in contrast to
women who had more HPV positive benign proliferative lesions
(32.4 vs 18.2%, respectively).
HPV was found statistically more often in a group of all
clinically visible oral lesions (17.7%) versus the control group (6.8%;
p= 0.023) with stronger association for lesions above oral mucosa
surface (18.6%; p= 0.0171) (Table 2). There was no statistically
significant difference between HPV positivity in lesions above
versus below oral mucosa (p.0.05). As expected, HPV was found
statistically more often in patients with any diagnosis (17.8%) versus
the control samples (6.8%; p= 0.0219). Although there was a
difference between potentially malignant disorders and controls in
HPV positivity, as well as inflammatory lesions compared to
controls, the difference did not reach statistical significance (15.5,
and 15.2 vs 6.8%, respectively; p.0.05). HPV positivity was only
significantly different between benign proliferative lesions versus the
control samples (22.7% vs 6.8%, respectively; p = 0.0056).
The overall HPV presence in samples of groups with different
clinical diagnosis is shown in Table 2. The determination of HPV
types 6/11, 16, 18, 31, 33, 45, 52, and 58 was successful in 50%
HPV-positive samples, and the other half remained untyped (HPV
X). As expected, most high-risk HPV types were found in
potentially malignant disorders, while in benign proliferative
lesions more HPV types X were detected. Apart of HPV X,
high-risk HPV 16 and HPV 31 were the most commonly found in
lesions above oral mucosa in 2.9% cases each, and particularly in
potentially malignant disorders in 4.3 and 3.4%, respectively. In
clinically apparently healthy mucosa HPV positivity was 6.8%,
and in all cases the type was not determined (HPV X).
Undetermined HPV types were also common in benign prolifer-
ative lesions and inflammatory lesions, found in 13.6 and 10.6%,
respectively, while less in potentially malignant disorders (3.4%).
Each analyzed sample had accompanying sampling location
information according to the modified WHO oral topography
coding [12]. Oral scrapings were taken from a single location in
34.5% cases, from 2 mostly adjacent locations in 29.5%, and more
than 2 locations in 7.4%. Scrapings of the ‘‘whole oral mucosa’’
were taken in 28.6% cases, mostly in case of clinically healthy oral
mucosa. Figure 1 graphically represents the distribution and
frequency of HPV positivity at different topographical regions of
the oral cavity.
Because of the limited number of subgroups of a particular
diagnosis-location combination we have grouped data according
to HPV frequency. For that we calculated the median and the
standard deviation of the total HPV frequency by location or
diagnosis, respectively. Moderate HPV frequency group included
the median and61/2 standard deviation. High frequency and low
frequency groups were above and below the moderate group,
respectively. The resulting findings are summarized in Table 3.
The Chi square test for trend was used on row-column subtotal
intersections within each subgroup of diagnosis (low, moderate,
high) to assess the influence of topography on disease subgroup.
The influence of diagnosis within each subgroup of topography
(low, moderate, high) was also assessed with the same test. The
statistical analysis indicated that HPV positivity significantly
correlates with the location in moderate and high HPV frequency
-diagnosis subgroups (p = 0.041 and p= 0.038, respectively), while
for low HPV frequency diagnosis group the p value was not
significant (p = 0.366). On the other hand, the diagnosis was
significantly affecting only the moderate HPV frequency topog-
raphy subgroup (p= 0.003), while it was not so for the high and
low frequency topography subgroups, p = 0.111 and p=0.054,
respectively. In summary, HPV positivity seems to be more
associated to particular location than diagnosis itself.
Discussion
This study is the only study on HPV prevalence in oral mucosal
lesions in the Croatian population. Although the collection of the
study population took 16 years, the advantage of this study is its
sample size and uniformity of material, sampling, and further
processing procedures. All the oral scrapings were taken in the
single clinic under the same conditions, and DNA preparation and
HPV analysis was also done in the same manner in the virological
Table 1. Distribution of oral lesion by morphology and diagnosis according to gender and HPV positivity irrespective of
topography.
Gender Women Men Total
HPV status Negative Positive Subtotal Negative Positive Subtotal
N % N % N % N % N % N % N %
Oral lesion morphology
All lesion of the oral mucosa 147 87.0 22 13.0 169 66.5 62 72.9 23 27.1 85 33.5 254 100
Lesions above oral mucosa 118 88.1 16 11.9 134 65.7 48 68.6 22 31.4 70 34.3 204 100
Lesions beneath oral mucosa 29 82.9 6 17.1 35 70.0 14 93.3 1 6.7 15 30.0 50 100
Clinically healthy oral mucosa 38 97.4 1 2.6 39 53.4 30 88.2 4 11.8 34 46.6 73 100
Subtotal 185 88.9 23 11.1 208 63.6 92 77.3 27 22.7 119 36.4 327 100
Oral lesion diagnosis
All diagnosis 157 87.2 23 12.8 180 66.7 65 72.2 25 27.8 90 33.3 270 100
Potential malignant disorders 73 92.4 6 7.6 79 68.1 25 67.6 12 32.4 37 31.9 116 100
Benign proliferative lesions 45 81.8 10 18.2 55 62.5 23 69.7 10 30.3 33 37.5 88 100
Inflammatory lesions 39 84.8 7 15.2 46 69.7 17 85.0 3 15.0 20 30.3 66 100
Normal mucosa (control) 38 97.4 1 2.6 39 53.4 30 88.2 4 11.8 34 46.6 73 100
Subtotal 195 89.0 24 11.0 219 63.8 95 76.6 29 23.4 124 36.2 343 100
doi:10.1371/journal.pone.0069736.t001
HPV in Oral Mucosa
PLOS ONE | www.plosone.org 3 July 2013 | Volume 8 | Issue 7 | e69736
T
a
b
le
2
.
H
P
V
g
e
n
o
ty
p
e
s
d
is
tr
ib
u
ti
o
n
ac
co
rd
in
g
to
o
ra
l
le
si
o
n
m
o
rp
h
o
lo
g
y
an
d
d
ia
g
n
o
si
s
ir
re
sp
e
ct
iv
e
o
f
to
p
o
g
ra
p
h
y.
H
P
V
st
a
tu
s
T
o
ta
l
N
e
g
a
ti
v
e
P
o
si
ti
v
e
a
H
P
V
1
6
H
P
V
3
1
H
P
V
3
3
H
P
V
5
2
H
P
V
5
8
H
P
V
6
/1
1
M
u
lt
ip
le
b
U
n
k
n
o
w
n
c
N
%
N
%
N
%
N
%
N
%
N
%
N
%
N
%
N
%
N
%
N
%
O
ra
l
le
si
o
n
m
o
rp
h
o
lo
g
y
A
ll
le
si
o
n
o
f
th
e
o
ra
l
m
u
co
sa
2
5
4
1
0
0
2
0
9
8
2
.3
4
5
1
7
.7
6
2
.4
8
3
.1
1
0
.4
1
0
.4
1
0
.4
4
1
.6
4
1
.6
2
0
7
.9
L
e
si
o
n
s
a
b
o
v
e
o
ra
l
m
u
co
sa
2
0
4
1
0
0
1
6
6
8
1
.4
3
8
1
8
.6
6
2
.9
6
2
.9
1
0
.5
1
0
.5
1
0
.5
4
2
.0
3
1
.5
1
6
7
.8
L
e
si
o
n
s
b
e
n
e
a
th
o
ra
l
m
u
co
sa
5
0
1
0
0
4
3
8
6
.0
7
1
4
.0
2
4
.0
1
2
.0
4
8
.0
C
li
n
ic
a
ll
y
h
e
a
lt
h
y
o
ra
l
m
u
co
sa
7
3
1
0
0
6
8
9
3
.2
5
6
.8
5
6
.8
S
u
b
to
ta
l
3
2
7
1
0
0
2
7
7
8
4
.7
5
0
1
5
.3
6
1
.8
8
2
.4
1
0
.3
1
0
.3
1
0
.3
4
1
.2
4
1
.2
2
5
7
.6
O
ra
l
le
si
o
n
d
ia
g
n
o
si
s
A
ll
d
ia
g
n
o
si
s
2
7
0
1
0
0
2
2
2
8
2
.2
4
8
1
7
.8
6
2
.2
8
3
.0
1
0
.4
1
0
.4
1
0
.4
4
1
.5
4
1
.5
2
3
8
.5
P
o
te
n
ti
a
l
m
a
li
g
n
a
n
t
d
is
o
rd
e
rs
1
1
6
1
0
0
9
8
8
4
.5
1
8
1
5
.5
5
4
.3
4
3
.4
1
0
.9
1
0
.9
1
0
.9
1
0
.9
1
0
.9
4
3
.4
B
e
n
ig
n
p
ro
li
fe
ra
ti
v
e
le
si
o
n
s
8
8
1
0
0
6
8
7
7
.3
2
0
2
2
.7
1
1
.1
2
2
.3
3
3
.4
2
2
.3
1
2
1
3
.6
In
fl
a
m
m
a
to
ry
le
si
o
n
s
6
6
1
0
0
5
6
8
4
.8
1
0
1
5
.2
2
3
.0
1
1
.5
7
1
0
.6
N
o
rm
a
l
m
u
co
sa
(c
o
n
tr
o
l)
7
3
1
0
0
6
8
9
3
.2
5
6
.8
5
6
.8
S
u
b
to
ta
l
3
4
3
1
0
0
2
9
0
8
4
.5
5
3
1
5
.5
6
1
.7
8
2
.3
1
0
.3
1
0
.3
1
0
.3
4
1
.2
4
1
.2
2
8
8
.2
a
H
P
V
ty
p
e
s
1
8
an
d
4
5
w
e
re
n
o
t
d
e
te
rm
in
e
d
in
an
y
ca
se
.
b
th
re
e
ca
se
s
w
it
h
H
P
V
6
/1
1
an
d
H
P
V
1
6
,
an
d
o
n
e
ca
se
w
it
h
H
P
V
6
/1
1
an
d
H
P
V
3
1
.
c
H
P
V
X
.
d
o
i:1
0
.1
3
7
1
/j
o
u
rn
al
.p
o
n
e
.0
0
6
9
7
3
6
.t
0
0
2
HPV in Oral Mucosa
PLOS ONE | www.plosone.org 4 July 2013 | Volume 8 | Issue 7 | e69736
laboratory. Clinical diagnosis of the oral lesions and sampling was
evaluated by a single specialist. In each case, oral epithelial cells
were taken with the cytobrush and biopsies were excluded from
this study. In addition, each specimen was classified according to
the WHO topography code [12] in order to evaluate the
relationship of HPV infection and oral lesions at the different
locations of the mouth.
Three sets of consensus primers were used to maximize the
identification of alpha-HPV DNA. In addition, genotyping for
specific HPV types was performed on all samples regardless of
consensus PCR result to further increase the HPV detection
sensitivity. Types selected for genotyping were chosen due to their
abundance in cervical carcinoma in the world [16]. Similar studies
of HPV detection in oral cells by PCR were done earlier
confirming the significant association of HPV positivity in oral
carcinoma, potentially malignant disorders such as oral leukoplakia,
oral lichen ruber planus, and epithelial dysplasia (reviewed in Syrja¨nen
et al., 2011) [10]. This study includes all the listed oral lesions
except oral carcinoma.
The HPV prevalence in healthy oral mucosa [17] and in oral
lesions [18] is higher in men than women both in our study and
the literature. However, regarding the different morphology and
diagnosis, herein no statistically significant difference was found
because of the low number of study subgroups.
As expected, the lesions with morphological changes above the
oral mucosa and benign proliferative lesions contained HPV most
often. Control samples of clinically healthy oral mucosa were HPV
positive in 6.8% cases, but contained only HPV X. The
comparable findings were found in recent systematic review by
Kreimer et al. (2010) [19] where they found 4.5% overall HPV
positivity in healthy subjects, of which 1.3% had HPV 16.
In this study, half of the detected HPV types with consensus
primers remained untyped (HPV X). They can represent other
alpha-HPV types since approximately 40 types infect the
anogenital and oral mucosa and in this study only the most
common were genotyped [6]. In addition, beta-HPV and gamma-
HPV, which mostly infect skin and are considered to be cutaneous
types, may also be present in the oral cavity and can be detected
with (PG)MY09/11 [20], and probably with other consensus
primers as well. The frequency of HPV X was the lowest in
potentially malignant oral disorders, which was expected since
these lesions are most often caused by the most common high-risk
HPV types and those types were genotyped herein. However, it
appears that oral benign proliferative lesions more often contain
either less common high-risk types or other HPV types and thus
remained untyped in this study. Such lesions are therefore less
likely to progress into carcinoma.
Figure 1. Frequency of HPV detection at different regions of the oral mucosa. The topography of the oral mucosa is coded according to
the modified WHO oral topography codes by Roed-Petersen and Roenstrup [12,22]: vermilion border - upper (13), lower (14), labial commissures -
right (15), left (16), labial mucosa - upper (17), lower (18), labial sulci - upper (21), lower (22), cheek (bucal mucosa) - right (19), left (20), buccal sulcus -
right upper (23) lower (24), buccal sulcus – left upper (25) lower (26), upper gingiva or edentulous alveolar ridge buccally - right (27), left (28), lower
gingiva or edentulous alveolar ridge - right (29), left (30), upper anterior gingiva and edentulous ridge labially (31), lower anterior gingiva or
edentulous ridge labially (32), upper posterior gingiva or edentulous alveolar ridge palatally - right (33), left (34), lower posterior gingiva or
edentulous alveolar ridge lingually - right (35), left (36), anterior gingiva or edentulous ridge palatally (37), and lingually (38), dorsum of the tongue -
right (39), left (40), base of the tongue - right (41), left (42), tip of the tongue (43), margine of the tongue - right (44), left (45), surface of the tongue -
right (46), left (47), frontal floor of mouth (48), lateral floor of mouth - right (49), left (50), hard palate - right (51), left (52), soft palate - right (53), left
(54), anterior tonsillar pillar - right (55), left (56); color scale indicates frequency of HPV positivity in the respective locations; for regions with less than
3 samples analysed the frequency was not calculated; symetrical regions were counted as one for the analysis.
doi:10.1371/journal.pone.0069736.g001
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Our results showed that topography plays a role in HPV
prevalence in oral lesions. Even though the same lesions were
found in different regions of the oral cavity, the HPV positivity was
higher in specific topographical regions irrespective of diagnosis. It
was not possible to analyze different diagnosis-topography
combinations due to small sample subgroups, thus the data were
grouped according to HPV frequency associated with the
diagnosis and topography of lesion (Table 3). The statistical
analysis has shown that HPV positivity of the lesions that belong to
the moderate or high HPV frequency-diagnosis subgroups is
significantly associated with location. The topography was not
significantly associated with low HPV frequency-diagnosis sub-
group as the number of HPV positive samples was very small, but
it was significantly associated with the moderate HPV frequency
topography subgroup. Undoubtedly, it is true that some particular
diagnosis are more associated with HPV and thus more often HPV
positive, however, these data show that topography of the lesion is
significantly associated to the HPV positivity of a particular lesion,
and even somewhat more than the diagnosis. One of the possible
explanations for the observed data is that the locations with the
highest HPV positivity (vermilion border, hard palate, labial mucosa
and labial commissures) are also the most frequently exposed sites to
microtrauma that is prerequisite for HPV infection transmission.
In our study, papillomas could be found throughout the oral
mucosa except ventral tongue and floor of the mouth. As
papillomas are mostly caused by HPV infection this finding is in
line with the view that HPV infection of the mouth is multifocal
[21]. In addition, leukoplakia was also present on all anatomic sites
and the most frequently on the tongue mucosa. In contrast, oral
lichen planus was found predominatly on buccal mucosa but with
the least HPV positivity, which is associated with the role of local
cellular immunity in its immunopathogenesis [22].
Although HPV infection is associated with potentially malignant
oral disorders it is not possible to predict the likelihood of an HPV
infection from the clinical features of these lesions [23]. Therefore,
it is important to know the topographic distribution of the HPV
infection, in other words, its affinity for particular anatomic sites
on oral mucosa, to be able to determine the risk and then follow-
up these regions more closely. Our study in this context
significantly contributes to better understanding of the field.
Our study is among the largest studies on oral HPV prevalence
published so far. From our findings it appears that HPV
prevalence in oral cavity in Croatian population is comparable
to nearby Italian population both for potentially malignant lesions
and normal mucosa [23], however our overall HPV prevalence is
on the lower end of reported oral HPV prevalence from other
studies.
One of the important findings of this study can partially
elucidate the large discrepancy of observed HPV prevalence in
previous studies as we have shown that in addition to the
association of HPV with some particular diagnosis, HPV is also
associated to individual anatomic sites or regions of the oral
mucosa. Thus, previous studies analyzing samples of a particular
diagnosis taken from different regions of oral cavity reached
different conclusions. Even though topographical coding was
available for a long time, very few studies, if any, noted the
sampling locations and this should be changed in the future to
make studies more comparable and reported HPV prevalence
more reliable.
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